Pharmaceutical

STAT+: Medicare’s new proposal to cover medical devices...

The medical device industry is split on whether a proposed new Medicare reimburs...

STAT+: BioMarin wins approval for gene therapy to treat...

The FDA on Thursday approved a gene therapy to treat people with hemophilia A, a...

Stop taking Ozempic before surgery, anesthesiologist gr...

Because they slow down digestion in early weeks, drugs like Ozempic and Mounjaro...

Listen: Novavax’s CEO promises a turnaround & how Lilly...

Can Novavax finally get it right? What's a "triple-G" drug? And is Novo Nordisk ...

Medical leaders decry Supreme Court decision on affirma...

Medical leaders reacted swiftly to the Supreme Court’s decision on affirmative a...

Q&A: How can the US maintain access to essential drugs?

Carrie Harney, the vice president of government and regulatory Affairs at US Pha...

Genprex’s Reqorsa gene therapy secures another FDA fast...

Genprex has announced that the FDA has granted fast-track designation for Reqors...

Pfizer’s Ngenla finally secures FDA approval following ...

Pfizer has announced that the FDA has approved Ngenla (somatrogon-ghla), a paedi...

Cellusion shares pipeline update for eye disease stem c...

Cellusion shares Phase I/II clinical development plans for its bullous keratopat...

The promising role of GLP-1RAs in NASH

Research has shown that GLP-1RAs may have the potential to treat chronic metabol...

CRISPR gene editing on human embryos may have dangerous...

Experts warn caution around CRISPR gene editing technology on human embryos as i...

FDA rejects Alvotech’s Humira biosimilar for the third ...

While Alvotech aims to file a new application, the FDA's rejection delays the dr...

AstraZeneca’s STRIDE shows improved outcomes for liver ...

AstraZeneca has announced impressive results for its STRIDE regimen, significant...

Lantidra wins FDA approval as first-ever type 1 diabete...

The FDA has announced that Lantidra, a cellular therapy for type 1 diabetes, has...

Tevogen to go public in $1.2bn SPAC deal

The T-cell therapeutics company expects to be listed on the NYSE after deal comp...

STAT+: Trump demands the U.S. pay no more for drugs tha...

In Trump fashion, the former president claimed in a video announcement that he i...